https://www.businesswire.com/news/home/20200212005738/en/

SAN DIEGO--(BUSINESS WIRE)--Feb 12, 2020--

Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the fourth quarter and the year ended December 31, 2019.